Dapoxetine - Yuhan CorporationAlternative Names: IMD dapoxetine; YHD 1044
Latest Information Update: 01 Dec 2015
At a glance
- Originator Yuhan
- Class Antidepressants; Benzylamines; Naphthalenes; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Premature ejaculation
Most Recent Events
- 23 Sep 2015 No recent reports on development identified - Phase-III for Premature ejaculation in South Korea (PO)
- 31 May 2012 Yuhan Corporation completes a phase I/IIa trial in Premature ejaculation in South Korea (NCT01419470)